Eli Lilly and Co - Company Profile

Powered by

All the data and insights you need on Eli Lilly and Co in one report.

  • Save hours of research time and resources with
    our up-to-date Eli Lilly and Co Strategy Report

  • Understand Eli Lilly and Co position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Eli Lilly and Co (Lilly) is a healthcare company that discovers, develops, and markets human healthcare products. The company offers medicines for cardiovascular conditions, diabetes, endocrinology, cancer, neurological problems, autoimmune disorders, men's health, and musculoskeletal problems. The company distributes its pharmaceutical health products through independent wholesale distributors. Lilly conducts research and development activities to discover and deliver innovative medicines. It promotes products through sales representatives and marketing agreements with other pharmaceutical companies. The company operates R&D facilities, and production and distribution facilities in North America, South America, Europe, the Middle East, Africa and Asia-Pacific. Lilly is headquartered in Indianapolis, Indiana, the US.

Gain a 360-degree view of Eli Lilly and Co and make more informed decisions for your business Gain a 360-degree view of Eli Lilly and Co and make more informed decisions for your business Find out more
Headquarters United States of America

Address Lilly Corporate Ctr, Drop Code 1094, Lilly Corporate Ctr, Indianapolis, 46285-0001


Telephone 1 317 2762000

No of Employees 43,000

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange LLY (NYSE)

Revenue (2022) $34.1B 19.6% (2022 vs 2021)

EPS XYZ

Net Income (2022) XYZ -16.1% (2022 vs 2021)

Market Cap* $842.0B

Net Profit Margin (2022) XYZ -29.8% (2022 vs 2021)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Eli Lilly and Co premium industry data and analytics

3,300+

Clinical Trials

Determine Eli Lilly and Co go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

1,300+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Eli Lilly and Co’s relevant decision makers and contact details.

1,200+

Catalyst Calendar

Proactively evaluate Eli Lilly and Co’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

580+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

570+

Pipeline Drugs

Identify which of Eli Lilly and Co’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

160+

Marketed Drugs

Understand Eli Lilly and Co’s commercialized product portfolio to stay one step ahead of the market.

90+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

70+

Sales & Consensus Forecasts

Understand the current and future drug revenue for Eli Lilly and Co and assess market opportunity for new entrants with patient population 8-year forecasts.

4

Investigators

Review investigator profiles and find information on trial contacts across Eli Lilly and Co, including performance indicators like number of completed trials, and linked attributes such as rehiring statistics.

8

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Eli Lilly and Co (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

Products and Services

Products Brands
Human Pharmaceutical -
Endocrinology Products Humalog
Neuroscience Products Humulin
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Eli Lilly and Co portfolio and identify potential areas for collaboration Understand Eli Lilly and Co portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2024 Financing Agreements In May, the company invested US$5.3 billion in its manufacturing plant in Lebanon, Indiana, the US.
2024 Contracts/Agreements In May, the company signed a multi-target research partnership with Totus Medicines to find small-molecule drug candidates against undisclosed targets.
2024 Contracts/Agreements In May, the company partnered with Aktis Oncology to develop anti-cancer radiopharmaceuticals utilizing Aktis Oncology's innovative miniprotein technology platform.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters Eli Lilly and Co Johnson & Johnson Merck & Co Inc Pfizer Inc AbbVie Inc
Headquarters United States of America United States of America United States of America United States of America United States of America
City Indianapolis New Brunswick Rahway New York North Chicago
State/Province Indiana New Jersey New Jersey New York Illinois
No. of Employees 43,000 131,900 72,000 88,000 50,000
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
David A. Ricks Chairman; Chief Executive Officer; President Executive Board 2017 56
Daniel M. Skovronsky, M.D., Ph.D. Executive Vice President; Chief Scientific Officer; President - Lilly Research Laboratories and Immunology Senior Management 2024 50
Alonzo Weems Executive Vice President - Enterprise Risk Management; Chief Ethics and Compliance Officer Senior Management 2021 53
Diogo Rau Executive Vice President; Chief Information and Digital Officer Senior Management 2021 49
Anne E. White Executive Vice President; President - Lilly Neuroscience Senior Management 2021 55
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Eli Lilly and Co key executives to enhance your sales strategy Gain insight into Eli Lilly and Co key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer